Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty492008Chief Executive Officer & Executive Director
Philip Hampton612015Non-Executive Chairman
Simon Dingemans502011Chief Financial Officer & Executive Director
Deryck Charles Maughan662004Senior Independent Non-Executive Director
Stephanie A. Burns, PhD602007Independent Non-Executive Director
Moncef Slaoui, PhD542006Executive Director & Chairman-Vaccines Division
Daniel K. Podolsky, PhD602006Independent Non-Executive Director
Roy Malcolm Anderson662007Independent Non-Executive Director
Stacey Cartwright502011Independent Non-Executive Director
Judy Carol Lewent652011Independent Non-Executive Director
Shareholders
NameShares%
BlackRock Investment Management (UK) Ltd. 199,772,316 4.11%
Legal & General Investment Management Ltd. 149,809,659 3.08%
Norges Bank Investment Management 98,481,000 2.02%
The Vanguard Group, Inc. 92,177,424 1.89%
Aberdeen Asset Investments Ltd. 78,074,493 1.60%
SAFE Investment Co., Ltd. 62,593,537 1.29%
Capital Research & Management Co. (Global Investors) 60,768,000 1.25%
Schroder Investment Management Ltd. 60,221,536 1.24%
M&G Investment Management Ltd. 57,613,837 1.18%
Threadneedle Asset Management Ltd. 57,320,346 1.18%
Holdings
NameShares%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,370,7806.22%851,770,537 USD
GlaxoSmithKline Pakistan Ltd. 263,010,09882.6%503,138,317 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,92646.4%122,734,165 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%115,888,676 USD
Theravance Biopharma Inc (TBPH) 8,299,21824.6%115,774,091 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6939.05%63,214,532 USD
GALAPAGOS (GLPG) 508,6441.32%29,193,073 USD
Allergy Therapeutics plc (AGY) 10,118,0001.85%3,300,188 USD
Response Genetics, Inc. (RGDX) 5,000,00012.9%1,825,000 USD
Serendex Pharmaceuticals A/S (SENDEX) 98,0100.65%77,174 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ALLERGAN PLC
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
GlaxoSmithKline plc : Connections
Rockefeller Family Trust, Inc.
Imperial College London
Royal Bank of Scotland Plc
European Federation of Pharmaceutical Industries & Assns
Business Council for Britain
Purdue Pharma, Inc.
National Academy of Sciences
Singapore Economic Development Board
The Council for Industry & Higher Education
The 100 Group
The Natural History Museum
National Theatre of Scotland
Harvey Nichols Group Ltd.
Biotechnology Industry Organization
GlaxoSmithKline, Inc.
The University of Texas Southwestern Medical Center
The University of Nottingham
Carnegie Hall Society, Inc.
Longwood Fund Management LLC
Lincoln Center for the Performing Arts, Inc.
Southwestern Medical Foundation
NYU Langone Medical Center
The Trilateral Commission
French Academy of Sciences
The British Museum
Pearson Education Ltd.
Federal Reserve Bank of New York
Burberry Spain SA
Pharmaceutical Research & Manufacturers of America
Napp Pharmaceutical Holdings Ltd.
American Academy of Arts & Sciences
United Kingdom Department for Business Innovation & Skills
Mundipharma International Ltd.
American Chemical Society
Massachusetts Institute of Technology
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE Eurotop 100, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem